Global Burden of Tracheal, Bronchus, and Lung Cancer in 2022
Author Information
Author(s): Rajesh Sharma, Jagdish Khubchandani, Carmen Martos
Primary Institution: National Institute of Technology Kurukshetra, India; New Mexico State University, USA
Hypothesis
This study aimed to examine the disease and economic burden of TBL cancers in 185 countries worldwide in 2022.
Conclusion
TBL cancer is a significant global cause of mortality, with high adult smoking rates persisting in many countries despite awareness of its risks.
Supporting Evidence
- There were 2.48 million incident cases and 1.82 million deaths due to TBL cancers in 2022.
- Eastern Asia had the largest burden of TBL cancers, accounting for around 51% of incident cases.
- Adult tobacco use prevalence was statistically significantly associated with TBL cancer burden.
Takeaway
Lung cancer is a big problem around the world, and many people still smoke even though they know it's bad for them.
Methodology
The study used GLOBOCAN 2022 data to estimate TBL cancer incidence and mortality rates and analyzed the association with tobacco use prevalence.
Potential Biases
Estimates for low and middle-income countries might be biased due to reliance on local or neighboring country registries.
Limitations
The study relied on secondary data, which may be biased due to varying data availability from cancer registries.
Participant Demographics
Males accounted for 63.4% of incident cases and 67.85% of deaths.
Statistical Information
P-Value
0.71
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website